ArticleThe Laryngoscope2025
Update of Long-Term Outcomes After Cricotracheal Resection for Idiopathic Subglottic Stenosis.
Article in The Laryngoscope, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Perioperative outcome and predictors of success after tracheal resection.Langenbeck's archives of surgery · 2026Article
- Update of Long-Term Outcomes After Cricotracheal Resection for Idiopathic Subglottic Stenosis.The Laryngoscope · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesIdiopathic subglottic stenosis (iSGS) is a rare disease in which patients develop dyspnea from recurrent tracheal granulation scar. We present our long-term outcomes after crico-tracheal resection (CTR) for iSGS at a high-volume tertiary care center. We update our previous report in 2018 with seven additional years of follow-up.
methodsA review was conducted with iSGS patients who underwent CTR between 1999 and 2017. Diagnosis of iSGS was based on history and bronchoscopy exam. Recurrence of iSGS was evaluated using survivability and the Kaplan-Meier curve. Management of recurrence post-CTR was investigated with Pearson correlation analysis.
resultsSixty-one patients with iSGS underwent CTR. Our population was 98% female. Twenty (33%) patients developed recurrence after CTR. The mean time to recurrence was 13.8 years (range = 0.8-16.3). Seven (11%) patients had not recurred up to 21.9 years post-CTR. There was a negative correlation (-0.45, p = 0.046) between age at recurrence and number of procedures per year to treat recurrent stenosis. Six (10%) patients were deceased from unrelated causes at follow-up and on average 6 years post-CTR (range = 0.8-15.8). One patient recurred prior to her death.
conclusionOur 2018 report included a mean recurrence time of 12.5 years (range = 0.8-14.3). This follow-up showed an even longer time to recurrence (average = 13.8 years). CTR is associated with a low recurrence rate of stenosis. Older patients may be better candidates for CTR than younger patients. Further research should investigate risk factors that predispose patients to recurrence after CTR. LEVEL OF EVIDENCE: 4:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.